1. Barrero, M. J., Boué, S. & Izpisúa Belmonte, J. C. Epigenetic Mechanisms that Regulate Cell Identity. Cell Stem Cell 7, 565–570 (2010).
2. Trojer, P. & Reinberg, D. Facultative Heterochromatin: Is There a Distinctive Molecular Signature? Mol. Cell 28, 1–13 (2007).
3. Hahn, M., Dambacher, S. & Schotta, G. Heterochromatin dysregulation in human diseases. J. Appl. Physiol. 109, 232–242 (2010).
4. Wutz, A. Gene silencing in X-chromosome inactivation: Advances in understanding facultative heterochromatin formation. Nat. Rev. Genet. 12, 542– 553 (2011).
5. Lyon, M. F. Gene Action in the X-chromosome of the Mouse (Mus musculus L.). Nature 190, 372–373 (1961).
6. Simon, M. D. et al. High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation. Nature 504, 465–469 (2013).
7. Clemson, C. M., McNeil, J. A., Willard, H. F. & Lawrence, J. B. XIST RNA paints the inactive X chromosome at interphase: Evidence for a novel RNA involved in nuclear/chromosome structure. J. Cell Biol. 132, 259–275 (1996).
8. Williams, L. H., Kalantry, S., Starmer, J. & Magnuson, T. Transcription precedes loss of Xist coating and depletion of H3K27me3 during X-chromosome reprogramming in the mouse inner cell mass. Development 138, 2049–2057 (2011).
9. Csankovszki, G., Nagy, A. & Jaenisch, R. Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J. Cell Biol. 153, 773–783 (2001).
10. McHugh, C. A. et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature 521, 232–236 (2015).
11. Lee, J. T., Lu, N. & Han, Y. Genetic analysis of the mouse X inactivation center defines an 80-kb multifunction domain. Proc. Natl. Acad. Sci. U. S. A. 96, 3836– 3841 (1999).
12. Sado, T., Wang, Z., Sasaki, H. & Li, E. Regulation of imprinted X-chromosome inactivation in mice by Tsix. Development 128, 1275–1286 (2001).
13. Sado, T. & Brockdorff, N. Advances in understanding chromosome silencing by the long non-coding RNA Xist. Philos. Trans. R. Soc. B Biol. Sci. 368, (2013).
14. Chaumeil, J. et al. Evolution from XIST-independent to XIST-controlled X- chromosome inactivation: Epigenetic modifications in distantly related mammals. PLoS One 6, 1–11 (2011).
15. Rens, W., Wallduck, M. S., Lovell, F. L., Ferguson-Smith, M. A. & Ferguson- Smith, A. C. Epigenetic modifications on X chromosomes in marsupial and monotreme mammals and implications for evolution of dosage compensation. Proc. Natl. Acad. Sci. U. S. A. 107, 17657–17662 (2010).
16. Wutz, A. & Jaenisch, R. A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Mol. Cell 5, 695–705 (2000).
17. Ohhata, T. & Wutz, A. Reactivation of the inactive X chromosome in development and reprogramming. Cell. Mol. Life Sci. 70, 2443–2461 (2013).
18. Huynh, K. O. & Lee, J. T. Inheritance of a pre-inactivated paternal X chromosome in early mouse embryos. Nature 426, 857–862 (2003).
19. Patrat, C. et al. Dynamic changes in paternal X-chromosome activity during imprinted X-chromosome inactivation in mice. Proc. Natl. Acad. Sci. U. S. A. 106, 5198–5203 (2009).
20. Sugimoto, M. & Abe, K. X chromosome reactivation initiates in nascent primordial germ cells in mice. PLoS Genet. 3, 1309–1317 (2007).
21. Takahashi, K. & Yamanaka, S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126, 663–676 (2006).
22. Maherali, N. et al. Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Widespread Tissue Contribution. Cell Stem Cell 1, 55–70 (2007).
23. Kobayashi, S. et al. Live imaging of X chromosome reactivation dynamics in early mouse development can discriminate naïve from primed pluripotent stem cells. Development. 143, 2958–2964 (2016).
24. Tran, T. H. Y. et al. Live cell imaging of X chromosome reactivation during somatic cell reprogramming. Biochem. Biophys. Reports 15, (2018).
25. Pasque, V. et al. X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency. Cell 159, 1681–1697 (2014).
26. Talon, I., Janiszewski, A., Chappell, J., Vanheer, L. & Pasque, V. Recent Advances in Understanding the Reversal of Gene Silencing During X Chromosome Reactivation. Front. Cell Dev. Biol. 7, 1–13 (2019).
27. Borensztein, M. et al. Contribution of epigenetic landscapes and transcription factors to X-chromosome reactivation in the inner cell mass. Nat. Commun. 8, 1297–1310 (2017).
28. Janiszewski, A. et al. Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming. Genome Res. 29, 1659–1672 (2019).
29. Navarro, P. et al. Molecular coupling of Tsix regulation and pluripotency. Nature 468, 457–460 (2010).
30. Payer, B. et al. Tsix RNA and the germline factor, PRDM14, link X reactivation and stem cell reprogramming. Mol. Cell 52, 805–818 (2013).
31. Chaumeil, J., Okamoto, I. & Heard, E. X-Chromosome Inactivation in Mouse Embryonic Stem Cells: Analysis of Histone Modifications and Transcriptional Activity Using Immunofluorescence and FISH. Methods Enzymol. 376, 405–419 (2003).
32. Chadwick, B. P. & Willard, H. F. Barring gene expression after XIST: Maintaining facultative heterochromatin on the inactive X. Semin. Cell Dev. Biol. 14, 359–367 (2003).
33. Okamoto, I., Otte, A. P., Allis, C. D., Reinberg, D. & Heard, E. Epigenetic Dynamics of Imprinted X Inactivation during Early Mouse Development. Science (80-. ). 303, 644–649 (2004).
34. Nishimura, K. et al. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming. Stem Cell Reports 3, 915–929 (2014).
35. Banaszynski, L. A., Chen, L., Maynard-Smith, L. A., Ooi, A. G. L. & Wandless, T. J. A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules. Cell 126, 995–1004 (2006).
36. Yoshiki, A. et al. The mouse resources at the RIKEN BioResource Center. Exp. Anim. 58, 85–96 (2009).
37. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows- Wheeler transform. Bioinformatics 26, 589–595 (2010).
38. Lo, H. S. et al. Allelic variation in gene expression is common in the human genome. Genome Res. 13, 1855–1862 (2003).
39. Carrel, L. & Willard, H. F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400–404 (2005).
40. Giorgetti, L. et al. Structural organization of the inactive X chromosome in the mouse. Nature 535, 575–579 (2016).
41. Akdemir, K. C. & Chin, L. HiCPlotter integrates genomic data with interaction matrices. Genome Biol. 16, 1–8 (2015).
42. Oki, S. et al. Ch IP ‐Atlas: a data‐mining suite powered by full integration of public Ch IP ‐seq data . EMBO Rep. 19, 1–10 (2018).
43. Bui, P. L. et al. Template Activating Factor-I α Regulates Retroviral Silencing during Reprogramming. Cell Rep. 29, (2019).
44. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
45. Gao, T. & Qian, J. EnhancerAtlas 2.0: An updated resource with enhancer annotation in 586 tissue/cell types across nine species. Nucleic Acids Res. 48, D58–D64 (2020).
46. Foung, S. K. H., Sasaki, D. T., Grumet, F. C. & Engleman, E. G. Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidine. Proc. Natl. Acad. Sci. U. S. A. 79, 7484–7488 (1982).
47. Kim, K. Y. et al. X chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports 2, 896–909 (2014).
48. Zvetkova, I. et al. Global hypomethylation of the genome in XX embryonic stem cells. Nat. Genet. 37, 1274–1279 (2005).
49. Vallot, C. et al. Erosion of X chromosome inactivation in human pluripotent cells initiates with XACT coating and depends on a specific heterochromatin landscape. Cell Stem Cell 16, 533–546 (2015).
50. Yang, F., Babak, T., Shendure, J. & Disteche, C. M. Global survey of escape from X inactivation by RNA-sequencing in mouse. Genome Res. 20, 614–622 (2010).
51. Li, S. M. et al. Transcriptome-wide survey of mouse CNS-Derived cells reveals monoallelic expression within novel gene families. PLoS One 7, 1–8 (2012).
52. Berletch, J. B. et al. Escape from X Inactivation Varies in Mouse Tissues. PLoS Genet. 11, 1–26 (2015).
53. Deng, X. et al. Bipartite structure of the inactive mouse X chromosome. Genome Biol. 16, 1–21 (2015).
54. Giorgetti, L. et al. Structural organization of the inactive X chromosome in the mouse. Nature 535, 575–579 (2016).
55. Boyd, Y., Blair, H. J., Cunliffe, P., Masson, W. K. & Reed, V. A phenotype map of the mouse X chromosome: Models for human X-linked disease. Genome Res. 10, 277–292 (2000).
56. Zheng, Y.-C. et al. A systemtic review of histone lysine-specific demethylase 1 and its inhibitors. Medidibal Res. Rev. 35, 1032–1071 (2015).
57. Lee, M. G., Wynder, C., Cooch, N. & Shiekhattar, R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437, 432–435 (2005).
58. Moindrot, B. et al. A Pooled shRNA Screen Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated Silencing. Cell Rep. 12, 562–572 (2015).
59. Jamaladdin, S. et al. Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 111, 9840–9845 (2014).
60. Saunders, A. et al. The SIN3A/HDAC Corepressor Complex Functionally Cooperates with NANOG to Promote Pluripotency. Cell Rep. 18, 1713–1726 (2017).
61. Heard, E. et al. Methylation of histone H3 at Lys-9 Is an early mark on the X chromosome during X inactivation. Cell 107, 727–738 (2001).
62. Zhang, J. et al. SNPdetector: A software tool for sensitive accurate SNP detection. PLoS Comput. Biol. 1, 0395–0404 (2005).
63. Mahler, K. L. et al. Sequence divergence of Mus spretus and Mus musculus across a skin cancer susceptibility locus. BMC Genomics 9, 1–12 (2008).
64. Tomoda, K. et al. Derivation conditions impact x-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 11, 91–99 (2012).
65. Nichols, J. & Smith, A. Naive and Primed Pluripotent States. Cell Stem Cell 4, 487–492 (2009).
66. Skrypek, N., Goossens, S., De Smedt, E., Vandamme, N. & Berx, G. Epithelial- to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity. Trends Genet. 33, 943–959 (2017).
67. Nishimura, K. et al. A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation. Stem Cell Reports 8, 787–801 (2017).
68. Moussaieff, A. et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21, 392–402 (2015).
69. Wang, T. et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 9, 575–587 (2011).
70. Engreitz, J. M. et al. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science (80-. ). 341, 1–9 (2013).
71. Marks, H. et al. Dynamics of gene silencing during X inactivation using allele- specific RNA-seq. Genome Biol. 16, 1–20 (2015).
72. Novo, C. L. et al. The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells. Genes Dev. 30, 1101–1115 (2016).
73. Gaspar-Maia, A., Alajem, A., Meshorer, E. & Ramalho-Santos, M. Open chromatin in pluripotency and reprogramming. Nat. Rev. Mol. Cell Biol. 12, 36– 47 (2011).
74. Houge, G., Oeffner, F. & Grzeschik, K. H. An Xp11.23 deletion containing PORCN may also cause angioma serpiginosum, a cosmetic skin disease associated with extreme skewing of X-inactivation. Eur. J. Hum. Genet. 16, 1027–1028 (2008).
75. Blinkenberg, E. et al. Angioma serpiginosum with oesophageal papillomatosis is an X-linked dominant condition that maps to Xp11.3-Xq12. Eur. J. Hum. Genet. 15, 543–547 (2007).
76. Arican, P. et al. A De Novo Xp11.23 Duplication in a Girl with a Severe Phenotype: Expanding the Clinical Spectrum. J. Pediatr. Genet. 07, 074–077 (2018).
77. Brown, C. J. & Willard, H. F. The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature 368, 154–156 (1994).
論文の公開元へ
